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Abstract
The 59 end of the IgH locus contains a cluster of DNaseI hypersensitive sites, one of which (HS1) was shown to be pro-B cell
specific and to contain binding sites for the transcription factors PU.1, E2A, and Pax5. These data as well as the location of
the hypersensitive sites at the 59 border of the IgH locus suggested a possible regulatory function for these elements with
respect to the IgH locus. To test this notion, we generated mice carrying targeted deletions of either the pro-B cell specific
site HS1 or the whole cluster of DNaseI hypersensitive sites. Lymphocytes carrying these deletions appear to undergo
normal development, and mutant B cells do not exhibit any obvious defects in V(D)J recombination, allelic exclusion, or
class switch recombination. We conclude that deletion of these DNaseI hypersensitive sites does not have an obvious
impact on the IgH locus or B cell development.
Citation: Perlot T, Pawlitzky I, Manis JP, Zarrin AA, Brodeur PH, et al. (2010) Analysis of Mice Lacking DNaseI Hypersensitive Sites at the 59 End of the IgH
Locus. PLoS ONE 5(11): e13992. doi:10.1371/journal.pone.0013992
Editor: Sebastian D. Fugmann, National Institute on Aging, United States of America
Received June 28, 2010; Accepted October 26, 2010; Published November 15, 2010
Copyright:  2010 Perlot et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was funded by National Institutes of Health R01 AI020047 (to FWA) and GM36064 (to PHB). FWA is an Investigator of the Howard Hughes
Medical Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: alt@enders.tch.harvard.edu
. These authors contributed equally to this work.
¤a Current address: IMBA, Institute of Molecular Biotechnology of the Austrian Academy of Sciences, Vienna, Austria
¤b Current address: Division of Molecular Genetics, Netherlands Cancer Institute, Amsterdam, The Netherlands
¤c Current address: Department of Immunology, Genentech, San Francisco, California, United States of America
Introduction
The variable region of an immunoglobulin heavy chain (IgH) is
assembled from V (variable), D (diversity), and J (joining) gene
segments that lie upstream of several IgH constant (C) region
exons in a process called V(D)J recombination [1]. The mouse IgH
locus contains large numbers of VH segments and multiple D and
JH segments but an individual IgH V(D)J exon is assembled from
only one VH, one D, and one JH segment.
V(D)J recombination of the IgH locus takes place in pro-B cells
in an ordered way such that D to JH recombination precedes VH
to DJH recombination [2]. In this regard, activation of the IgH
locus is thought to progress in a stepwise manner [3]. D to JH
rearrangement efficiently occurs on both alleles, however, allelic
exclusion ensures that VH to DJH recombination results in
expression of a functional heavy chain (HC) from only one of
the two alleles [4].
Mature B-cells can undergo further alterations of their HCs.
IgH class switch recombination (CSR) causes expression of
different immunoglobulin isotypes which confer different effector
functions. During this recombination process one of several sets of
downstream CH exons replaces the Cm exons and the intervening
sequence is deleted from the chromosome, which results in
expression of a new C region without changing the specificity of
the IgH variable region [5].
A large effort has been made to elucidate mechanisms of IgH
locus regulation and a number of cis-regulatory elements have
been described and characterized. The IgH intronic enhancer (Em)
resides in the JH –C H intron and was shown to be necessary for
efficient V(D)J recombination by promoting both D to JH and VH
to DJH recombination [6,7]. Downstream of the CH genes at the
very 39 end of the IgH locus a cluster of DNaseI hypersensitive
sites was described, termed 39 IgH regulatory region (39IgH RR).
So far two main functions have been assigned to this regulatory
region: the 39IgH RR plays an important role in promoting CSR
to most IgH isotypes, and the 39IgH RR was shown to be
necessary for high level expression of the functionally assembled
HC gene from the promoter 59 of the VHDJH exon [8].
An additional potential regulatory region was identified at the 59
end of the IgH locus, consisting of four DNaseI hypersensitive sites
[9]. One of these sites, HS1, was shown to be pro-B cell specific,
the stage during which IgH V(D)J recombination takes place, and
was suggested to include binding sites for the transcription factors
PU.1, Pax5 and E2A [9]. These observations led to the suggestion
that this region might represent a new regulatory region for IgH
rearrangements. In this regard, the 59 end of the IgH locus is an
attractive location for a regulatory element because it would not be
deleted during the course of V(D)J recombination, and it might
explain control of several unresolved phenomena in the IgH locus.
Among these is the regulation of VH germline transcripts as so far
PLoS ONE | www.plosone.org 1 November 2010 | Volume 5 | Issue 11 | e13992no cis-regulatory element has been identified that controls activity
of the bulk of unrearranged VH promoters. Furthermore, it is not
known how it is achieved that proximal and distal VH segments
are activated independently or why usage of distal versus proximal
VH gene families varies significantly.
Here we report the targeted deletion of the pro-B cell specific
59IgH HS1 as well as combined deletion of HS1, HS2, HS3a,b in
mice. We analyzed potential implications on B cell development,
V(D)J recombination, and IgH CSR.
Methods
Targeted deletion of 59IgH DNaseI hypersensitive sites in
ES cells and generation of mutant mice
All mouse were handled in strict accordance with good animal
practice as defined by the relevant national and/or local animal
welfare bodies, and all animal work was approved by Animal
Research of Children’s Hospital Boston (Protocol # 08 11 1253R).
The RHS1 targeting vector was assembled in pLNTK [10]. As a
59 homology arm a 2.2 kb PCR product was generated with
primers 59 GTCGACGGATTTAGGAGGATACACAAC 39 and
59 GTCGACCTTGGATAACACAGAACTCTG 39 containing a
SalI site at their 59 ends, which facilitate cloning of the PCR
product into the SalI site of pLNTK. As a 39 homology arm a 7.3
kb AatII – ApaI fragment was blunt end cloned into the XhoI site
of pLNTK. The R39HSs targeting vector was generated by blunt
end cloning a 4.4 kb EcoRI fragment into the SalI site of pLNTK
as a 59 homology arm, and a 7.0 kb KpnI fragment into the XhoI
site as the 39 homology arm. Correct targeting events and cre –
loxP deletion events were confirmed by Southern blotting (Fig 1).
Probe 1 is a 830 bp PCR product amplified with primers 59
GCTCATGTACCAATCTGCACTCAC 39 and 59 CACTGT-
GACCTCCATCTTATGTCTG 39. Probe 2 is a 1.2 kb PstI –
EcoRI fragment 59 of HS2. Probe 3 is a 0.8 kb PstI – XbaI
fragment about 11 kb 39 of HS3b. To confirm single integration of
the targeting vectors a 525 bp Neo
R probe was used, amplified
with primers 59 GCAGCCATATGGGATCGGC 39 and 59
GTTCGGCTGGCGCGAGCCCC 39.
EF1 heterozygous IgH
a/b embryonic stem (ES) cells, generated
in the Alt laboratory, were transfected with PvuI linearized RHS1
targeting vector to obtain RHS1/+ ES cells. To obtain DHS1/+ ES
cells, the PGK-Neo
R cassette was deleted by applying a Cre –
expressing adenovirus vector. DHS1/+ ES cells were transfected
with PvuI linearized R39HSs targeting vector to obtain R39HSs/+
ES cells. R39HSs/+ ES cells were selected for homozygocity of the
targeted allele through increasing concentration of G418 to obtain
R39HSs/R39HSs ES cells. Cre – loxP mediated deletion of the
PGK-Neo
R cassette resulted in DHSs/DHSs ES cells. Targeted ES
cells were injected into Rag2-/- blastocysts to obtain RDBC
chimeras [11] or into C57BL/6 blastocysts to obtain chimeras that
could be crossed to 129Sv mice to achieve germline transmission
of the targeted allele.
B cell hybridomas
CD43
- splenocytes were isolated by MACS, stimulated with
LPS (20 mg/ml), and fused to NS-1 plasmacytoma cells (TIB-18,
ATCC) as described previously [12]. IgH V(D)J rearrangement
status was analyzed by Southern blotting of EcoRI digested
genomic DNA of clonal hybridomas with three different probes, a
1.6 kb HindIII - EcoRI fragment 39 of JH4, a 0.38 kb SacI - ApaI
fragment 39 of DHQ52, and a 0.75 kb PCR product 59 of
DHFL16.1 generated with oligonucleotides 59 GAACAG-
CAACCCTTGACTGACTCTG 39 and 59 GATTGGTTCT-
TATGGAATGGGTGG 39.
PCR assay for V(D)J rearrangements
Pro-B cells (IgM
- B220
+ CD43
hi), pre B-cells (IgM
- B220
+
CD43
lo), and double positive T-cells (B220
- CD4
+ CD8
+) were
isolated by FACS on a FACSAria (BD Biosciences) and genomic
DNA was extracted. 50 ng DNA or 5-fold dilutions were analyzed
by PCR for DH–JH,V H-DJH,V k–Jk, and Vl–Jl rearrangements
with primers listed in Table S1. Input DNA amounts were
normalized upon PCR amplification within DLG5. PCR was
performed at 95uC for 49, 30 cycles of 95uC for 300,6 0 uC for 900,
and 72uC for 29, followed by 72uC for 59. PCR products were
transferred from ethidium bromide gels to nylon membranes and
visualized with end labeled oligonucleotide probes (Table S1).
CDR 3 lengths were generated from IgH VDH rearrangements
from mature B cells using oligonucleotides for V558 and JH4
rearrangements. PCR fragments were amplified using iProof (Bio-
Rad) polymerase and cloned into Zero Blunt Topo vectors
(Invitrogen), and sequenced.
IgH class switch recombination assay
CD43
- splenocytes were isolated by MACS, cultured with LPS
or IL4/aCD40, and analyzed by flow cytometry as described
previously [13].
RT-PCR analysis
RNA was extracted using TriPure Isolation Reagent (Roche).
200 ng–1 mg of total RNA was reverse transcribed for one hour at
50uC using random hexamers (Roche) and Superscript III
(Invitrogen) reverse transcriptase. PCR was performed at 94uC
for 49, 30–39 cycles of 94uC for 300, annealing temperature (Table
S1) for 300,7 2 uC for 300, followed by 72uC for 59. cDNA input
amount was normalized upon PCR amplification of b-actin
cDNA. PCR products were visualized on ethidium bromide gels
and/or subsequently transferred to nylon membranes and
visualized with end labeled oligonucleotide probes (Table S1).
Flow cytometry and cell sorting
Single cell suspensions from spleen, thymus, or bone marrow
were stained in PBS 2% FBS with various antibodies: FITC-aIgM,
PE-Cy5-aB220, PE-aCD8a, PE-aCD43, FITC-aLy9.1, APC-
aIgM, APC-Cy7-aB220 (BD Pharmingen), PE-aAA4.1, FITC-
aCD4 (eBioscience). FACS analysis was performed on a
FACSCalibur (BD Biosciences) and a FACSAria (BD Biosciences)
apparatus. Cell sorts were performed on a FACSAria (BD
Biosciences) apparatus.
Results
Generation of mice with targeted deletion of 59IgH
DNaseI hypersensitive sites
To determine the in vivo function of the cluster of DNaseI
hypersensitive sites described at the 59 end of the IgH locus [9] we
first replaced a ,340 bp BccI – AatII fragment, harboring HS1,
with a loxP flanked PGK-Neo
R cassette. All targeting experiments
were performed in heterozygous IgH
a/b EF1 ES cells which have
the advantage that IgH
a (129 strain) and IgH
b (C57BL/6 strain)
alleles can be distinguished by antibodies against the different
allotypes or by detection of restriction fragment length polymor-
phisms (RFLP). Targeting vector homology arms were cloned from
129 strain genomic DNA, resulting in correct targeting events only
on the IgH
a allele. In heterozygous targeted ES cells, the IgH
b allele
always remained in the untargeted wildtype configuration.
Targetings were performed with the RHS1 targeting vector
(Fig. 1A) to obtain the RHS1 allele and, upon cre/loxP deletion,
59IgH Enhancer
PLoS ONE | www.plosone.org 2 November 2010 | Volume 5 | Issue 11 | e13992Figure 1. Targeting strategy for the generation of the RHS1, DHS1, and DHSs alleles. (A) the wildtype (wt) IgH locus and its 59 flanking
region are shown. VH,D H,J H indicate representative IgH V, D, and J segments. Exons 1, 2, and 3 of Zfp386 are shown as grey rectangles, DNaseI
hypersensitive sites HS1, HS2, HS3a, and HS3b are shown as black ovals. Correct targeting events of the RHS1 targeting vector were identified by
Southern blotting on BglII digested ES cell DNA using probe 1, which results in a 15.8 kb band (lane 1) in addition to the 14.2 kb wildtype band (lane
2). Cre – loxP (black triangles) mediated deletion of the PGK-Neo
R cassette (NeoR) from the RHS1 allele results in the DHS1 allele. Deletions were
identified by Southern analysis of SacI digested DNA utilizing probe 2. A targeted clone before Cre – mediated deletion exhibits a 6.7 kb RHS1 band
and a 5.1 kb wildtype band (lane 3). Upon deletion of the PGK-Neo
R cassette, a 4.8 kb DHS1 band and a 5.1 kb wildtype band are visible (lane 4). Lane
5 shows untargeted wildtype DNA. (B) The DHS1 allele was targeted with the R39HSs targeting vector to introduce a PGK-Neo
R cassette flanked by
loxP sites. Correct targeting events were confirmed by Southern blotting on SphI digested ES cell DNA with probe 1, resulting in a 2.6 kb band for the
wildtype IgH
b allele and a 7.2 kb band for R39HSs, the targeted IgH
a allele (lane 6). Cre – mediated recombination between the first and the third loxP
site generates the DHSs allele (14.1 kb, lane 8). Homozygous R39HSs ES cells were generated under increasing concentrations of G418, resulting in a
single 7.2 kb R39HSs band (lane 7). Southern analysis on SphI digested DNA with probe 3 confirms correct targeting events of the R39HSs targeting
vector. DHS1 ES cells exhibit a 15.7 kb DHS1 band and a 26.3 kb band for the wildtype IgH
b allele (lane 9), R39HSs ES cells show a 11.1 kb R39HSs band
and a 26.3 kb band for the wildtype IgH
b allele (lane 11), DHSs ES cells are identified by the presence of a 14.1 kb DHSs band in addition to the
26.3 kb wildtype IgH
b allele (lane 10). All targeting events occured on the IgH
a allele, whereas the IgH
b allele remained in wildtype configuration.
Drawings not to scale. B - BglII; S - SacI; P - SphI.
doi:10.1371/journal.pone.0013992.g001
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integration of the targeting vector (Figure S1) were confirmed by
Southern blotting. Subsequently, targeted ES cells were injected
into Rag2-/- blastocysts to obtain Rag-deficient blastocyst
complementation (RDBC) chimeras, and into wildtype blastocyts
to generate mice that carry the RHS1 or DHS1 allele in their
germline. In order to delete all four hypersensitivity sites (HS1,
HS2, HS3a, and HS3b), ES cells containing the DHS1 allele were
targeted with the R39HSs targeting vector to obtain the R39HSs
allele (Fig. 1B). Cre/loxP recombination between the loxP site
originating from the DHS1 allele and the loxP site 39 of the PGK-
Neo
R cassette results in the replacement of a 8.9 kb region,
harboring all described 59IgH DNaseI hypersensitive sites, with a
single loxP site, referred to as the DHSs allele. Germline
transmission could not be achieved for either of the R39HSs or
DHSs heterozygous ES cell lines. Therefore, we placed ES cells
containing the R39HSs allele under increasing concentrations of
G418 to select for homozygous mutant ES cells. The homozygous
mutant ES cells were subsequently subjected to cre/loxP
recombination to delete the Neo
r gene and generate ES cells
homozygous for the DHSs allele. The homozygous mutant DHSs
ES cells were injected into Rag2
-/- blastocysts, and chimeras
generated by RDBC and lymphocytes were analyzed.
Development of homozygous RHS1, DHS1, and DHSs
lymphocytes
Lymphocytes of different developmental stages can be identified
by FACS analysis of cells from lymphoid tissues such as bone
marrow, thymus, or spleen. We analyzed 8 week old wildtype
mice, homozygous RHS1, and homozygous DHS1 mice that carry
the mutant alleles in their germline, as well as lymphocytes from
RDBC chimeras generated from homozygous DHSs ES cells
(Fig. 2). In wildtype bone marrow, pro-B cells can be identified as
IgM
- B220
+ CD43
hi and pre-B cells as IgM
- B220
+ CD43
lo cells,
respectively. Defects in B-cell development can be revealed by the
increase or decrease of certain lymphocyte populations. In this
regard, impaired IgH V(D)J recombination leads to an accumu-
lation of pro-B cells and to reduced numbers of pre-B cells [7]. We
performed FACS analyses of bone marrow from three mice of
each genotype to measure the percentage of pro- and pre-B cells in
the lymphocyte gate. These analyses revealed the average
percentage (6 standard deviation) of pro-B and pre-B cells,
respectively of B220
+/CD43
+ events in the total lymphocyte gate
were 1462 and 50620 for wildtype, 963 and 5666 for DHS1,
and 963 and 42611 for RHS1 mice (Fig. 2A). Thus, there were
no obvious differences in early B-cell development in wildtype and
mutant mice. However we cannot exclude minor developmental
defects not readily detectable by such analyses. Homozygous
mutant DHSs bone marrow cells were analyzed in a similar
fashion, but only Ly9.1
+ cells were included in the analysis. Ly9.1
is exclusively expressed on cells derived from the DHSs ES cells
but not on cells derived from the Rag2-/- blastocyst. The presence
of a large compartment of blastocyst derived Rag-deficient pro-B
cells in the bone marrow can interfere with development of ES cell
derived B-lymphocytes. However, FACS analysis of DHSs bone
marrow B cells indicated the presence of both pro- and pre-B cells
and did not suggest a block in B-cell development (Fig. 2A).
Next we analyzed spleens for IgM
+ B220
+ AA4.1
+ transitional
B-cells and IgM
+ B220
+ AA4.1
- mature B-cells (Fig. 2B). In
homozygous RHS1, and homozygous DHS1 mice transitional
(19.7%–27.5%) and mature (65.3%–72.7%) B-cell compartments
similar to wildtype were identified; whereas, in spleens from
RDBC chimeras generated from homozygous DHSs ES cells
strongly reduced numbers of transitional B-cells were observed
(6.44%). This reduction in the transitional B-cell compartment
compared to the mature B-cell compartment (75%) might be due
to overall reduced numbers of developing B cells in the obtained
RDBC chimeras and to the accumulation of mature B-cells in the
periphery of these mice and not to a defect in B cell development.
Finally, we observed normal development of T-lymphocytes in the
thymi of wildtype, homozygous RHS1, and homozygous DHS1
mice as well as RDBC chimeras generated from homozygous
DHSs ES cells (Fig. 2C).
The DHS1, RHS1, and DHSs alleles show no significant
defect in V(D)J recombination
The data indicating that HS1 is pro-B cell specific and contains
binding sites for the transcription factors PU.1, Pax5, and E2A led
to the suggestion that HS1 could be involved in regulation of
V(D)J recombination at the IgH locus [9]. We utilized a PCR
based assay to assess V(D)J recombination efficiencies in
developing lymphocytes from mice with homozygous deletion of
HS1. FACS-sorted pro-B cells (IgM
- B220
+ CD43
hi) and pre-B
cells (IgM
- B220
+ CD43
lo) from bone marrow and double positive
(DP) T-cells (B220
- CD4
+ CD8
+) from thymus were analyzed for
Dt oJ H,V H to DJH,V k to Jk and Vl to Jl rearrangements.
Intensities of PCR bands for DHQ52 to JH (Fig. 3A) and DSP to JH
rearrangements (Fig. 3B) were comparable in pro-B cells, pre-B
cells, and DP T-cells from wildtype, homozygous RHS1, and
homozygous DHS1 mice indicating that deletion of the pro-B cell
specific HS1 site does not detectably affect the D to JH
recombination step. DNA input amounts were normalized to the
presence of a genomic sequence within the murine DLG5 gene
(Fig. 3H).
It was speculated that HS1 might regulate the differential
activation of distal versus proximal VH families [9]; therefore, we
analyzed the rearrangement efficiencies of the proximal VH7183
family (Fig. 3C), the distal VHJ558 familiy (Fig. 3D), and the distal
most VH segment VHJ558.55 (Fig. 3E). We found that pro-B cells
and pre-B cells from wildtype, homozygous RHS1, and homozy-
gous DHS1 mice rearrange the proximal VH7183 family at similar
levels (Fig. 3C). Also, the distal family VHJ558 (Fig. 3D) as well as
the distal most VH segment VHJ558.55 (Fig. 3E) rearranged at
comparable efficiencies in pro-B cells and pre-B cells from the
three different genotypes. VH to DJH recombination was absent in
DP T-cells from wildtype, homozygous RHS1, and homozygous
DHS1 mice as the VH to DJH recombination step is restricted to
the B-lineage (Fig 3C, D, E). These data show that HS1 is not
Figure 2. Development of homozygous DHS1, RHS1, and DHSs lymphocytes. (A) Bone marrow from wildtype (wt), homozygous DHS1,
homozygous RHS1 mice, and RDBC chimeras generated from homozygous DHSs ES cells was subjected to FACS analysis. Gates were set on the
lymphocyte population, Ly9.1 positive population, and on IgM negative population (upper three blots, left to right) to analyze pro-B cell (IgM
- B220
+
CD43
hi) and pre-B cell (IgM
- B220
+ CD43
lo) populations (lower blots). (B) FACS analysis of splenocytes from wildtype (wt), homozygous DHS1,
homozygous RHS1 mice, and RDBC chimeras generated from homozygous DHSs ES cells. Gates were set on the lymphocyte population and on the
IgM positive population (upper two blots, left to right) to analyze transitional B-cell (IgM
+ B220
+ AA4.1
+) and mature B-cell (IgM
+ B220
+ AA4.1
-)
populations (lower blots). (C) FACS analysis of thymocytes gated on the lymphocyte population (upper blot) from wildtype (wt), homozygous DHS1,
homozygous RHS1 mice, and RDBC chimeras generated from homozygous DHSs ES cells (lower blots).
doi:10.1371/journal.pone.0013992.g002
59IgH Enhancer
PLoS ONE | www.plosone.org 5 November 2010 | Volume 5 | Issue 11 | e13992Figure 3. V(D)J recombination in DHS1 and RHS1 mice. Pro-B cells, pre-B cells and double positive (DP) T-cells from wildtype 129 mice, from
homozygous DHS1, and homozygous RHS1 mice were sorted by FACS. 5-fold dilutions of genomic DNA were subjected to PCR analysis. IgH V(D)J
recombination efficiencies were assessed using a reverse primer downstream of JH4 and a forward primer recognizing DQ52 (A), DSPs (B), the VH7183
family (C), the VHJ558 family (D), or the VHJ558.55 segment (E). Rearrangements can occur to JH1, JH2, JH3, or JH4 as indicated. GL indicates PCR
product from germline configuration. Igk rearrangements were quantified (F), rearrangements can occur to Jk1, Jk2, Jk4, or Jk5 as indicated. Igl
rearrangement efficiency was analyzed (G). Bands correspond to Vl2-J l2, Vl1-J l3, or Vl1-J l1 rearrangements as indicated. DNA input was
normalized to DLG5 PCR products (H).
doi:10.1371/journal.pone.0013992.g003
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and, therefore, suggest that HS1 does not play a major role in
regulation of usage or accessibility of distal versus proximal VH
families.
Recently, it has been shown that IgH and Igk loci can colocalize
during B-cell development, mainly at the pre-B cell stage, and it
was suggested that this colocalization induces decontraction of the
IgH locus [14]. We therefore performed an assay to evaluate Igk
(Fig. 3F) and Igl (Fig. 3G) V(D)J recombination efficiencies. Both
Igk and Igl loci show similar V(D)J recombination levels in the
analyzed developing B cells from wildtype, homozygous RHS1,
and homozygous DHS1 mice, while light chain rearrangements
were absent in DP T-cells from the three different genotypes.
Therefore, we conclude that deletion of HS1 does not markedly
affect Ig light chain gene rearrangements.
As an independent method to evaluate D to JH and VH to DJH
recombination efficiencies, we generated clonal hybridoma lines
from splenic B-cells of IgH
a/b heterozygous RHS1, DHS1 mice
carrying the mutant allele in their germline and of RDBC
chimeras generated from heterozygous DHSs ES cells (Table 1). In
each case the IgH
a allele was the mutant allele while the IgH
b
allele was the wildtype allele. In splenic B-cells, one allele exists as
a functional VHDJH rearrangement, while the second allele can
either be in germline configuration, or it exists as a DJH or an
nonproductive VHDJH rearrangement. The rearrangement status
of the second IgH allele was assessed by Southern blot analysis.
Consequently, hybridomas expressing the mutant IgH
a allele can
be analyzed for rearrangement efficiency of the wildtype IgH
b
allele, and vice versa, in hybridomas expressing the wildtype IgH
b
allele, the rearrangement status of the mutant IgH
a allele can be
assessed.
Wildtype B cells undergo D to JH rearrangements on both
alleles; but still, consistent with earlier studies, about 5% of
hybridomas harbor an IgH allele in germline configuration which
presumably originates from tripartite fusions involving non B-cells
[12] (not shown). The number of mutant alleles in germline
configuration was not increased compared to wildtype indicating
that RHS1, DHS1, and DHSs alleles can undergo efficient D to JH
recombination (not shown). In 50–60% of wildtype B-cells the
nonproductive allele is in DJH configuration; whereas in 40–50%
the nonproductive allele is in VHDJH configuration [15]. An
increased percentage of DJH alleles could indicate less efficient VH
to DJH recombination: in contrast, an increased percentage of
VHDJH alleles might indicate a break in allelic exclusion. IgM
a
expressing hybridomas generated from B-cells heterozygous for
RHS1, DHS1, and DHSs were analyzed for their rearrangement
status of the wildtype IgM
b allele and show ratios of DJH (56%–
61%), and VHDJH alleles (39%–44%) in the expected range
(Table 1). IgM
b expressing hybridomas were analyzed for the
Table 1. DHS1, RHS1, and DHSs hybridoma analysis.
DJ VDJ-
DHS1 IgM
a+ 66 (61%) 43 (39%)
DHS1 IgM
b+ 52 (57%) 39 (43%)
RHS1 IgM
a+ 62 (56%) 49 (44%)
RHS1 IgM
b+ 45 (52%) 41 (48%)
DHSs IgM
a+ 51 (61%) 32 (39%)
DHSs IgM
b+ 55 (69%) 25 (31%)
Hybridomas were generated from heterozygous IgM
a/b DHS1, RHS1,a n dDHSs
splenic B-cells. In each case, IgM
b is the wildtype allele and IgM
a is the mutant
allele. IgM
a expressing hybridomas (IgM
a+) and IgM
b expressing hybridomas
(IgM
b+) of each genotype were analyzed for the rearrangement status of their
nonproductive allele. Numbers for D to JH rearranged alleles (DJ) and
nonproductive VH to DJH rearranged alleles (VDJ-) are shown.
doi:10.1371/journal.pone.0013992.t001
Figure 4. IgM
a versus IgM
b expression in DHS1, RHS1, and DHSs B cells. Heterozygous IgM
a/b B-cells from spleen (A) and bone marrow (B) of
129 wildtype (wt) or DHS1, RHS1, and DHSs RDBC chimeras were analyzed IgM
a and IgM
b expression. In DHS1, RHS1, and DHSs B-cells the IgM
b allele is
in wildtype configuration whereas the IgM
a allele is the mutant allele.
doi:10.1371/journal.pone.0013992.g004
59IgH Enhancer
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a allele. RHS1, DHS1,
and DHSs alleles do not show significantly increased or decreased
(Fisher’s exact test) rearrangement ratios compared to wt alleles, as
52%–69% of mutant alleles were in DJH configuration while
31%–48% were in VHDJH configuration.
FACS analysis was performed on B-cells from spleens (Fig. 4A)
and bone marrow (Fig. 4B) of RDBC chimeras generated from
heterozygous RHS1, DHS1, and DHSs ES cells. IgM
a expressing
populations, representing the targeted allele, and IgM
b expressing
populations, representing the wildtype allele, were of similar size
both in bone marrow and in spleen from RHS1, DHS1, and DHSs
chimeras, suggesting that the RHS1, DHS1, and DHSs alleles can
undergo V(D)J recombination at the IgH locus at similar
efficiencies as wildtype alleles.
The DHS1, RHS1, and DHSs alleles do not affect allelic
exclusion
FACS analysis of wt B cells from spleen (Fig. 4A) and bone
marrow (Fig. 4B) shows distinct populations of similar size for B
cells that are single positive for either IgH
a or IgH
b, but intact
allelic exclusion prevents the appearance of an obvious IgH
a, IgH
b
double producing population. Similarly, RDBC chimeras gener-
ated from heterozygous RHS1, DHS1, and DHSs ES cells exhibited
IgH
a or IgH
b single positive B-cell populations of similar size in
spleen (Fig. 4A) and bone marrow (Fig. 4B) but no IgH
a, IgH
b
double producing population. These data indicate that the deleted
sequences of the targeted alleles do not contain a regulatory
element that is necessary for implementation of allelic exclusion.
Furthermore, data from hybridoma analysis (Tab. 1) support this
notion as in the case of a break in allelic exclusion increased
numbers of hybridomas with VH to DJH rearrangements on both
alleles would be expected. Such an increase compared to wildtype
alleles could not be observed (Tab. 1), which indicates intact allelic
exclusion of RHS1, DHS1, and DHSs alleles.
The 59IgH DNaseI hypersensitive sites are not required
for efficient class switch recombination
To assess a potential effect of the 59IgH DNaseI hypersensitive
sites on CSR, B-cells were stimulated to undergo CSR and
analyzed by FACS (Fig. 5). Stimulation with LPS induces IgH
isotype switching to c3, while stimulation with IL4+ aCD40
promotes switching to c1. B-cells from AID-/- mice served as
negative controls, while wildtype B-cells represented a positive
control and therefore switched to the appropriate isotypes under
LPS or IL4+ aCD40 stimulation. CSR in homozygous DHSs B-
cells occurs at similar levels as in wildtype B-cells implying that the
cluster of 59IgH DNaseI hypersensitive sites is not required for
efficient CSR to c1 (Fig. 5A) and c3 (Fig. 5B).
Complex phenotypes without an obvious relation to the
IgH locus in DHS1 mice
We performed targeted deletion experiments of the 59IgH
DNaseI hypersensitive sites to test their suggested function in IgH
locus regulation. So far no major IgH related phenotype was
identified. However, about 20% of homozygous DHS1 mice
develop a complex neurological phenotype and die at 3–5 weeks of
Figure 5. Ig class switch recombination in absence of the 59IgH DNaseI hypersensitive sites. MACS purified splenic B-cells were
stimulated in culture with LPS or IL4+ aCD40 as indicated. FACS analysis shows B-cells that underwent CSR as B220
+ IgG1
+ or B220
+ IgG3
+ cells,
respectively. AID
-/- B-cells served as negative controls, wildtype (wt) 129 B-cells as positive controls. Homozygous DHSs B-cells were isolated from
RDBC chimeras.
doi:10.1371/journal.pone.0013992.g005
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abnormal limp grasping phenotype, i.e. mice clasp their front and
hind feet almost immediately upon being lifted by their tail
(Fig. 6A, B). Furthermore these mice develop a hydrocephalus,
which is already visible at about one week of age and is enlarged
over the following weeks (Fig. 6C, D). Histological analysis
confirmed the presence of a hydrocephalus, revealed abnormal
hindbrain development, and revealed retinal abnormalities
(Fig. 6E, F, G). The wildtype retina is organized in a delicate
layer system (Fig. 6E): stratum opticum and ganglionic layer (1),
inner plexiform layer (2), inner nuclear layer (3), outer plexiform
layer (4), outer nuclear layer (5), layer of rods and cones (6),
pigment layer (7). In the DHS1 mutant mice, the organization of
retinal layers is impaired in such a way that nuclei from the outer
nuclear layer are aberrantly located in the layer of rods and cones
(Fig. 6F). In some more severe cases rosette formation in the outer
nuclear layer is evident (Fig. 6G). Currently, we do not know what
causes these phenotypes, but we exclude that this phenotype is
caused by a second integration of the targeting vector at an
undefined site in the genome (Figure S1). The deletion in the
DHS1 allele deletes 340 bp within intron 1 of Zfp386. Therefore,
misregulation of that poorly described gene might cause the
described phenotypes although other possibilities are conceivable.
Discussion
This study aimed for elucidating the potential regulatory
functions of a cluster of recently described DNaseI hypersensitive
sites at the 59 end of the IgH locus [9]. We performed targeted
deletion of either the pro-B cell specific site HS1 (DHS1)o r
deletion of the entire cluster of hypersensitive sites (DHSs) in mice
or in their lymphocytes, respectively. A potential regulatory
element at the 59end of the IgH locus was speculated to regulate
processes such as IgH allelic exclusion, VH germline transcription,
differential accessibility or usage of distal versus proximal VH gene
families. Furthermore, it was suggested that the 59end of the IgH
locus might play a role in positioning the IgH locus in distinct
subnuclear compartments [16,17,18], and it was suggested to
harbor insulator or boundary capacity [19].
B- and T-lymphocytes homozygous for the DHS1, RHS1, and
DHSs alleles appear to proceed through lymphocyte development
in an unimpaired way. Data from RDBC chimeras generated from
Figure 6. Complex phenotypes of homozygous DHS1 mice. Homozygous DHS1 mice exhibit an abnormal limp grasping phenotype (B)
whereas wildtype (wt) mice do not (A). DHS1 mice can develop severe hydrocephalus as indicated by arrows in (C) and (D). A wildtype mouse without
hydrocephalus is shown in (C). The wildtype retina is organized in distinct layers (E): Stratum opticum and ganglionic layer (1), inner plexiform layer
(2), inner nuclear layer (3), outer plexiform layer (4), outer nuclear layer (5), layer of rods and cones (6), pigment layer (7). The retina of homozygous
DHS1 mice shows external nuclei from the outer nuclear layer (5) in the layer of rods and cones (6) indicated by arrows in (F), or rosette formation of
the outer nuclear layer (5) indicated by arrows in (G).
doi:10.1371/journal.pone.0013992.g006
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allelic exclusion is not affected in mutant B-cells and that mutant
IgH alleles can undergo efficient V(D)J recombination of their IgH
locus. Furthermore, data from PCR assays to analyze V(D)J
recombination efficiency in mice with HS1 deleted on both alleles
supports the notion that HS1 is not necessary for neither the D to
JH nor the VH to DJH recombination step. Both proximal and
distal VH families as well as the distal most VH segment VHJ558.55
rearrange as efficiently as on wildtype alleles. Similarly, IgL loci in
HS1 deleted B-cells rearrange at the same efficiency as wildtype
IgL loci. Analysis of IgH V(D)J rearrangement status in
hybridomas generated from heterozygous DHS1, RHS1, and DHSs
B-cells also strengthens the idea that the deleted DNAseI
hypersensitive sites would not regulate IgH V(D)J recombination.
We tested for potential alterations associated with DNA end
processing during V(D)J recombination by examining the CDR3
sequence obtained from homozygous DHS1 B cells and found a
distribution in length that was similar to wildtype B cells [20]
(Figure S2).
We tested a potential effect of the cluster of DNaseI
hypersensitive site on the process of IgH CSR. Assaying class
switching upon different in vitro stimulations in wildtype and
homozygous DHSs B-cells let us conclude that the cluster of 59IgH
DNaseI hypersensitive sites does not play a crucial role in CSR.
The only observed phenotypes so far occurred in homozygous
DHS1 mice and seem to be independent of the IgH locus. DHS1
mice show abnormal limp grasping indicating a neurological
abnormality, DHS1 mice can develop severe hydrocephalus and
exhibit retinal impairments. A possible explanation for these
phenotypes is a potential defect in regulation of the zinc finger
protein Zfp386. DHS1 deletes a 340 bp region from intron 1 of
Zfp386 which might result in different splice forms, impaired
expression levels, or expression patterns of this gene.
Overall, our analysis of the deletion of the pro-B cell specific site
HS1 or the whole cluster of 59IgH DNaseI hypersensitive sites did
not support the existence of a cis-regulatory function of these
elements regarding the IgH locus.
Supporting Information
Figure S1 Single integration of the RHS1 targeting vector. The
targeting vector (targeting vector RHS1), the targeted locus
(RHS1), and the wildtype (wt) IgH locus with its 59 flanking
region are shown. VH, DH, JH indicate representative IgH V, D,
and J segments. Exons 1, 2, and 3 of Zfp386 are shown as grey
rectangles, DNaseI hypersensitive sites HS1, HS2, HS3a, and
HS3b are shown as black ovals, the NeoR specific Southern probe
as a black rectangle. X - XbaI. Southern analysis of XbaI digested
genomic DNA from the targeted RHS1 clones 5 (lane 1) and 23
(lane 2) utilizing the NeoR specific probe shows a single 16.0 kb
band. No bands are visible from untargeted wildtype ES cell DNA
(lane 3). M - Fermentas 1 kb ladder.
Found at: doi:10.1371/journal.pone.0013992.s001 (0.17 MB TIF)
Figure S2 CDR3 length in DHS1 B cells. Peripheral B cells were
isolated from one DHS1 mouse and a wildtype mouse and
amplified for V558-JH4 rearrangements. Heavy Chain CDR3
lengths were calculated as the number of nucleotides between the
consensus Cys residue and the Trp residue. 23 individual
sequences were analyzed from DHS1 B cells and 10 from wildtype.
Found at: doi:10.1371/journal.pone.0013992.s002 (0.05 MB
PDF)
Table S1
Found at: doi:10.1371/journal.pone.0013992.s003 (0.08 MB
DOCX)
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